Exhaled breath hydrogen cyanide as a marker of early pseudomonas aeruginosa infection in children with cystic fibrosis

ERJ Open Research

Volumn 1, Issue 2, 2015, Pages

  Gilchrist, Francis J ^a,b   Belcher, John ^c   Jones, Andrew M ^d   Smith, David ^b   Smyth, Alan R ^e   Southern, Kevin W ^f   Španěl, Patrik ^g   Kevin Webb, A ^d   Lenney, Warren ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^g J HEYROVSKÝ INSTITUTE OF PHYSICAL CHEMISTRY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85019538550     PISSN: None     EISSN: 23120541     Source Type: Journal    
DOI: 10.1183/23120541.00044-2015     Document Type: Article

References (28)

1. Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002; 34: 91-100.
2. Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001; 138: 699-704.
3. Valerius NH, Koch C, Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338: 725-726.
4. Langton Hewer SC, Smyth AR. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev 2009: CD004197.
5. Douglas TA, Brennan S, Gard S, et al. Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. Eur Respir J 2009; 33: 305-311.
6. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999; 28: 321-328.
7. Armstrong DS, Grimwood K, Carlin JB, et al. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996; 21: 267-275.
8. De Boeck K, Alifier M, Vandeputte S. Sputum induction in young cystic fibrosis patients. Eur Respir J 2000; 16: 91-94.
9. Al-Saleh S, Dell SD, Grasemann H, et al. Sputum induction in routine clinical care of children with cystic fibrosis. J Pediatr 2010; 157: 1006-1011.e1.
10. Brennan S, Gangell C, Wainwright C, et al. Disease surveillance using bronchoalveolar lavage. Paediatr Respir Rev 2008; 9: 151-159.
11. Clawson BJ, Young CC. Preliminary report on the production of hydrocyanic acid by bacteria. J Biol Chem 1913; 15: 419-422.
12. Carroll W, Lenney W, Wang T, et al. Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry. Pediatr Pulmonol 2005; 39: 452-456.
13. Gilchrist FJ, Alcock A, Belcher J, et al. Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa. Eur Respir J 2011; 38: 409-414.
14. Gilchrist FJ, Sims H, Alcock A, et al. Quantification of hydrogen cyanide and 2-aminoacetophenone in the headspace of Pseudomonas aeruginosa cultured under biofilm and planktonic conditions. Anal Methods 2012; 4: 3661-3665.
15. Williams HD, Zlosnik JEA, Ryall B. Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa. Adv Microb Physiol 2007; 52: 1-71.
16. Gilchrist FJ, Sims H, Alcock A, et al. Is hydrogen cyanide a marker of Burkholderia cepacia complex? J Clin Microbiol 2013; 51: 3849-3851.
17. Enderby B, Smith D, Carroll W, et al. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol 2009; 44: 142-147.
18. Gilchrist FJ, Bright-Thomas RJ, Jones AM, et al. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection. J Breath Res 2013; 7: 026010.
19. Spaněl P, Smith D. Progress in SIFT-MS: breath analysis and other applications. Mass Spectrom Rev 2011; 30: 236-267.
20. Spanel P, Dryahina K, Smith D. A general method for the calculation of absolute trace gas concentrations in air and breath from selected ion flow tube mass spectrometry data. Int J Mass Spectrom 2006; 249: 230-239.
21. Španěl PSD. Selected Ion Flow Tube mass Spectrometry (SIFT-MS) for on-line trace gas analysis of breath. Clin Diagn Ther Monit. 2005; 3-34.
22. Gilchrist FJ, Razavi C, Webb AK, et al. An investigation of suitable bag materials for the collection and storage of breath samples containing hydrogen cyanide. J Breath Res 2012; 6: 036004.
23. Spanĕl P, Wang T, Smith D. Quantification of hydrogen cyanide in humid air by selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 2004; 18: 1869-1873.
24. Genders TSS, Spronk S, Stijnen T, et al. Methods for calculating sensitivity and specificity of clustered data: a tutorial. Radiology 2012; 265: 910-916.
25. Lee TWR, Brownlee KG, Conway SP, et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003; 2: 29-34.
26. Schmidt FM, Metsälä M, Vaittinen O, et al. Background levels and diurnal variations of hydrogen cyanide in breath and emitted from skin. J Breath Res 2011; 5: 046004.
27. Wang T, Pysanenko A, Dryahina K, et al. Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity. J Breath Res 2008; 2: 037013.
28. Lee TWR. Eradication of early Pseudomonas infection in cystic fibrosis. Chron Respir Dis 2009; 6: 99-107.